Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

ABSTRACT: This study is designed as Phase II/III. Phase II is aimed to evaluate safety and efficacy of IRIS, and feasibility of FOLFIRI. Phase III is aimed to verify inferiority of the progression free survival of IRIS in comparison with FOLFIRI.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2025803 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR